KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

ClearPoint Neuro (CLPT) Shares Issued (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Shares Issued for 11 consecutive years, with $3.3 million as the latest value for Q2 2025.

  • Quarterly Shares Issued rose 120.51% to $3.3 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $3.3 million through Dec 2025, up 15438.1% year-over-year, with the annual reading at $3.3 million for FY2025, 15438.1% up from the prior year.
  • Shares Issued hit $3.3 million in Q2 2025 for ClearPoint Neuro, up from -$267000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $16.2 million in Q1 2024 to a low of -$15.9 million in Q2 2024.
  • Historically, Shares Issued has averaged $352166.7 across 4 years, with a median of $117500.0 in 2021.
  • Biggest YoY gain for Shares Issued was 364.39% in 2021; the steepest drop was 99.14% in 2021.
  • Year by year, Shares Issued stood at -$119000.0 in 2021, then surged by 279.83% to $214000.0 in 2022, then crashed by 224.77% to -$267000.0 in 2024, then skyrocketed by 1322.1% to $3.3 million in 2025.
  • Business Quant data shows Shares Issued for CLPT at $3.3 million in Q2 2025, -$267000.0 in Q3 2024, and -$15.9 million in Q2 2024.